ArticleNarra J2021
Molecular docking of two cytotoxic compounds from
Article in Narra J, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed, 25 citations in OpenAlex.
- Phytocompounds ofNarra J · 2023Article
- Antioxidant and phytometabolite profiles of ethanolic extract from the cascara pulp ofF1000Research · 2023Article
- Acceleration of wound healing by topical application of gel formulation ofF1000Research · 2022Article
- Molecular docking investigation of calotropone as a potential natural therapeutic agent against pancreatic cancer.Journal of advanced pharmaceutical technology & researchArticle
- Bioactive phytoconstituents of ethanolic extract fromJournal of advanced pharmaceutical technology & researchArticle
- Probing antibacterial drugs forJournal of advanced pharmaceutical technology & researchArticle
- Cytotoxicity and phytochemical profiles ofJournal of advanced pharmaceutical technology & researchArticle
- Antibacterial activities of seven ethnomedicinal plants from familyJournal of advanced pharmaceutical technology & researchReview
- Antioxidant and antiproliferative activities of n-hexane extract and its fractions fromJournal of advanced pharmaceutical technology & researchArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors at 3 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The utilization of natural compounds as therapeutic agents to treat pancreatic cancer has recently focused on natural drug research.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.